Cancer Care
 

Lawrence's Select Breast and Colon Performance Measures and Outcomes for 2011

NewYork-Presbyterian/Lawrence Hospital's Cancer Care program annually submits data on all of its cancer patients to the National Cancer Database (NCDB). The NCDB then reviews the information and issues its findings concerning NewYork-Presbyterian/Lawrence's ability to meet national treatment guidelines. This is its report on breast and colon cancer cases diagnosed in 2011 at Lawrence.

  Measure Estimated Performance Rates
B

R

E

A

S

T
Radiation therapy is administered within 1 year (365 days) of diagnosis for women under age 70 and who received a lumpectomy. 100%
Combination chemotherapy is considered or administered within 4 months (120 days) of diagnosis for women under 70 with a breast tumor between 1 – 2 cm, Stage II or Stage II, ER and PR negative breast cancer. 100%
Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year (365 days) of diagnosis for women with a breast tumor between 1 – 2 cm, Stage II or Stage III, ER and or PR positive breast cancer. 88.9%
C

O

L

O

N
Post surgery chemotherapy is considered or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with Stage III (lymph node positive) colon cancer. 90.9%
At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer. 100%